Dublin, Ireland

William Finlay

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: William Finlay: Innovator in Therapeutic Antibodies

Introduction

William Finlay is a distinguished inventor based in Dublin, Ireland. He has made significant contributions to the field of therapeutic antibodies, holding a total of 3 patents. His work focuses on innovative solutions for treating diseases related to tumor necrosis factor-like ligands.

Latest Patents

Among his latest patents, Finlay has developed antibodies that specifically bind to tumor necrosis factor (TNF)-like ligand 1A (TL1A). The first patent provides methods for obtaining these antibodies and nucleic acids encoding them. It also details compositions and therapeutic methods for using these antibodies in the treatment and prevention of TL1A-mediated diseases, disorders, or conditions. The second patent mirrors the first, focusing on tumor necrosis factor-like ligand A (TLA) and its therapeutic applications.

Career Highlights

Finlay has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of biotechnology.

Collaborations

Throughout his career, Finlay has collaborated with notable professionals, including Robert Arch and Jun Zhang. These partnerships have further enhanced his research and innovation efforts.

Conclusion

William Finlay is a notable inventor whose work in therapeutic antibodies has the potential to impact the treatment of various diseases. His patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…